OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Publication Date
Release Date
2015
(3)
2017
(2)
2014
(2)
2024
(1)
2016
(1)
2013
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial.
Not available
S-EPMC4251960
|
biostudies-literature
Cite
Collaborative Research in Childhood Cancer Survivorship: The Current Landscape.
Not available
S-EPMC4567704
|
biostudies-literature
Cite
Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study.
Not available
S-EPMC3871511
|
biostudies-literature
Cite
Neurocognitive function and CNS integrity in adult survivors of childhood hodgkin lymphoma.
Not available
S-EPMC3462045
|
biostudies-literature
Cite
Age-dependent changes in health status in the Childhood Cancer Survivor cohort.
Not available
S-EPMC4314595
|
biostudies-literature
Cite
Human Papillomavirus Vaccination Rates in Young Cancer Survivors.
Not available
S-EPMC5662846
|
biostudies-literature
Cite
CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.
Not available
S-EPMC5070560
|
biostudies-literature
Cite
Individual prediction of heart failure among childhood cancer survivors.
Not available
S-EPMC4314592
|
biostudies-literature
Cite
Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.
Not available
S-EPMC5678343
|
biostudies-literature
Cite
Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.
Not available
S-EPMC3927733
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets